Stay updated on DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma

Sign up to get notified when there's something new on the DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma page.
Latest website image capture
Clouds background image

Latest updates to the DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Core content reduction: the MedlinePlus Genetics topic on multiple myeloma was removed, narrowing the page’s coverage of genetics-related information on that disease.
    Difference
    0.2%
    Check dated 2025-10-20T13:00:20.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Added MedlinePlus Genetics topic: Multiple myeloma (expands core content and resources on genetics and disease).
    Difference
    0.2%
    Check dated 2025-10-13T07:32:58.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    - Added a government operating status notice and a version bump to v3.2.0. - Removed the old version tag v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T04:59:10.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Terminology updated from Plasma cell myeloma to Multiple myeloma and the page version advanced from v3.0.2 to v3.1.0; two new identifiers were added.
    Difference
    0.2%
    Check dated 2025-09-29T02:54:51.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Removed a MedlinePlus Genetics topic on multiple myeloma. No new content added.
    Difference
    0.2%
    Check dated 2025-09-21T22:26:46.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    Added MedlinePlus Genetics topic: Multiple myeloma and updated the revision to v3.0.2; removed the old revision note (v3.0.1) and the Back to Top link.
    Difference
    0.4%
    Check dated 2025-09-14T18:53:58.000Z thumbnail image

Stay in the know with updates to DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma

Enter your email address, and we'll notify you when there's something new on the DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma page.